Ebola virus discoverer Peter
Piot speaks after an informal consultation at the World Health Organization.
|
Peter Piot, a Belgian
scientist who was one of a group in Zaire who discovered Ebola in 1976, said to
the BBC that the vaccines would take time to develop however he was encouraged
by the progress made in Sierra Leone, Liberia and Guinea.
The spread of the virus,
which has peaked in Liberia, is likely to cause a rapid increase in infections
in Sierra Leone during the next few weeks while the vaccines take around three
months to prove their effectiveness, the director of the London School of
Hygiene and Tropical Medicine added.
“The Ebola epidemic is
still very much there. People are still dying, new cases are being detected,”
he told the BBC World Service's Newsday programme.
“We need to be ready for
a long effort, a sustained effort [for] probably the rest of 2015.”
The numbers of infections
in Guinea have fluctuated with around 1,525 deaths, with no new cases reported
in Mali since 24 November, the latest World Health Organization statistics show.
He also attributed the
British government’s involvement in deploying health care workers and supplying
vital equipment needed to deal with the rapid numbers of that are being
admitted into treatment centres run by charities and humanitarian aid funds.
“Treatment centres have
now been established across the country with British help. You don't see any
longer the scenes where people are dying in the streets,” he said.
Around 14 British medical
workers walked out of a treatment centre run by an Italian NGO called Emergency
in the Sierra Leone capital of Freetown on Monday after they believed the Amiodarone drug, which was previously untested on animals or humans with the
virus, was being used to treat Ebola patients, according to the Guardian.
The charity stopped using
the drug after a request by the British government’s Department of
International Development. The Guardian also reported that Emergency is
planning a formal medical trial for the drug.
Amiodarone, which has
serious side-effects, is also confirmed by the British Medical Journal to have
been used by Emergency in a new 100-bed hospital that opened to Ebola sufferers
with the help of a £250million foreign aid fund from the UK.
No comments:
Post a Comment